NEW YORK – April 25, 2025 – Global law firm Greenberg Traurig, LLP represented Patient Square Capital (Patient Square) as health care regulatory counsel in connection with its acquisition of Patterson Companies, Inc. for approximately $4.1 billion.
Headquartered in St. Paul, Minnesota, Patterson Companies is an international distributor of products, technologies, services, and business solutions for the animal and oral health industries.
Patient Square is a dedicated health care investment firm with approximately $11 billion in assets under management as of Sept. 30, 2024. Patient Square aims to achieve strong investment returns by partnering with growth-oriented companies and top-tier management teams whose products, services, and technologies improve health.
The Greenberg Traurig team that represented Patient Square and was led by Health Care & FDA Practice Shareholders Nicholas J. Diamond in Houston, Tamara Rizkalla in Washington D.C., Julie A. Sullivan, Esq., MPH, CPC in Denver, and James Peacock in Dallas. They were assisted by Ejim Peter Achi, co-chair of Greenberg Traurig’s Global Corporate Practice and Private Equity Practice, Shareholder Shaun Levor in the Corporate Practice in New York, Associates Alexander M. Mandel in the Corporate Practice in New York, Sascha James Alach in the Corporate Practice in New York, Nicole Galli Baptista in the Health Care & FDA Practice in Washington D.C., Abdulrasheed Bolaji Ijaodola in the Corporate Practice in New York, Tyler Strobel in the Health Care & FDA Practice in Denver, Ashley Wollaston in the Health Care & FDA Practice in Houston, and Law Clerk Vincent Okonkwo in the Corporate Practice in New York.